1-20 of 74
L. Miller
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT120: Phase 1 trial of bortezomib and clofarabine combination in adults with refractory solid tumors

Andre L. De Souza, Naoko Takebe, Alice P. Chen, James H. Doroshow, Ralph E. Parchment, Apurva K. Srivastava, Lawrence Rubistein, Deborah Wilsker, Brandon L. Miller, Murielle Hogu, Geraldine O`Sullivan Coney, Shivaani Kummar, Jeevan Govindharajulu, Robert Meehan, William G. Herrick, Angie Dull, Donna Ketchum, Shaowei Li, Jiuping Ji, Richard Piekarz
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): CT120.
https://doi.org/10.1158/1538-7445.AM2024-CT120
Published: 05 April 2024
View article titled, Abstract CT120: Phase 1 trial of bortezomib and clofarabine combination in adults with refractory solid tumors
Journal Articles

Abstract 2582: Intra- and peri-tumoral radiomic features are predictive of pathologic response to multiple neoadjuvant therapy regimen in rectal cancers via pre-treatment MRI

Leo Bao, Thomas DeSilvio, Benjamin N. Parker, Mohsen Hariri, Prathyush Chirra, Murad Labbad, Stephen Tang, Gregory M. O'Connor, Emily Steinhagen, Jennifer L. Miller-Ocuin, Amit Gupta, Eric L. Marderstein, Aaron Carroll, Marka Crittenden, Michael J. Gough, Smitha Krishnamurthi, Kristina H. Young, Satish E. Viswanath
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 2582.
https://doi.org/10.1158/1538-7445.AM2024-2582
Published: 22 March 2024
View article titled, Abstract 2582: Intra- and peri-tumoral radiomic features are predictive of pathologic response to multiple neoadjuvant therapy regimen in rectal cancers via pre-treatment MRI
Journal Articles

Abstract 5100: Multimodal real world data reveals immunogenomic drivers of acquired and primary resistance to immune checkpoint blockade

Mohamed Reda Keddar, Sebastian Carrasco Pro, Kathleen Burke, Ana Camelo Stewart, Mark Cobbold, Ross Stewart, Sajan Khosla, Ben Sidders, Scott Hammond, Douglas C. Palmer, Jonathan Dry, Martin L. Miller
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 5100.
https://doi.org/10.1158/1538-7445.AM2024-5100
Published: 22 March 2024
View article titled, Abstract 5100: Multimodal real world data reveals immunogenomic drivers of acquired and primary resistance to immune checkpoint blockade
Journal Articles

Abstract 4737: The combination of the BET inhibitor JQ1 and gemcitabine induces regressions in gemcitabine resistant patient-derived xenograft models of pancreatic cancer

Aubrey L. Miller, Samuel C. Fehling, Eric Josh Brown, Eric O. Heard, Tracy L. Gamblin, Rebecca B. Vance, Karina J. Yoon
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 4737.
https://doi.org/10.1158/1538-7445.AM2024-4737
Published: 22 March 2024
View article titled, Abstract 4737: The combination of the BET inhibitor JQ1 and gemcitabine induces regressions in gemcitabine resistant patient-derived xenograft models of pancreatic cancer
Journal Articles

DAB2IP Is a Bifunctional Tumor Suppressor That Regulates Wild-Type RAS and Inflammatory Cascades in KRAS Mutant Colon Cancer

Abigail L. Miller, Naiara Perurena, Alycia Gardner, Toshinori Hinoue, Patrick Loi, Peter W. Laird, Karen Cichowski
Journal: Cancer Research
Cancer Res (2023) 83 (11): 1800–1814.
https://doi.org/10.1158/0008-5472.CAN-22-0370
Published: 02 June 2023
View article titled, DAB2IP Is a Bifunctional Tumor Suppressor That Regulates Wild-Type RAS and Inflammatory Cascades in KRAS Mutant Colon Cancer
Open the PDF for DAB2IP Is a Bifunctional Tumor Suppressor That Regulates Wild-Type RAS and Inflammatory Cascades in KRAS Mutant Colon Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 5074: Addition of MAPK inhibitors to prime and sensitize poorly differentiated thyroid cancers as a strategy to improve TSHR-CART cell therapy antitumor activity

Claudia Manriquez Roman, Kendall J. Schick, Justyna J. Gleba, Truc N. Huynh, Elizabeth L. Siegler, James L. Miller, Aylin Alasonyalilar Demirer, Matthew L. Pawlush, Ahmet Biligili, Long K. Mai, Erin Tapper, Leo R. Sakemura, Michelle J. Cox, Carli M. Stewart, Ismail Can, Ekene J. Ogbodo, Gaofeng Cui, Georges Mer, Gloria R. Olivier, Yushi Qiu, Robert C. Smallridge, Zubair C. Abba, Han W. Tun, John A. Copland, Saad S. Kenderian
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 5074.
https://doi.org/10.1158/1538-7445.AM2023-5074
Published: 04 April 2023
View article titled, Abstract 5074: Addition of MAPK inhibitors to prime and sensitize poorly differentiated thyroid cancers as a strategy to improve TSHR-CART cell therapy antitumor activity
Journal Articles

Abstract 1697: The development of an in vivo model of checkpoint acquired resistance, reveals a program of interferon hyperstimulation, resulting in dysregulation of MHC class I, protein translation/trafficking, and other unique pathways, that may be useful for guiding clinical strategy in patients with phenotypic similarities

George J. Fromm, Danish Memon, Suresh de Silva, Kyung Jin Yoo, Kellsey Johannes, Casey Shuptrine, Jaya Miriyala, Arpita Patel, Fatima Rangwala, Zachary Opheim, Thuy-Ai Nguyen, Louis Gonzalez, Fatima Rangwala, Taylor H. Schreiber, Matthew D. Hellmann, Martin L. Miller, Taylor H. Schreiber
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1697.
https://doi.org/10.1158/1538-7445.AM2021-1697
Published: 01 July 2021
View article titled, Abstract 1697: The development of an in vivo model of checkpoint acquired resistance, reveals a program of interferon hyperstimulation, resulting in dysregulation of MHC class I, protein translation/trafficking, and other unique pathways, that may be useful for guiding clinical strategy in patients with phenotypic similarities
Journal Articles

Abstract 1484: SCD-1 blockade sensitizes triple negative breast cancer to immune checkpoint inhibition

Sneha Vivekanandhan, Justyna Trynda, Laura A. Marlow, Barath shreeder, James L. Miller, Adam M. Kase, Winston Tan, Keith L. Knutson, John A. Copland
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1484.
https://doi.org/10.1158/1538-7445.AM2021-1484
Published: 01 July 2021
View article titled, Abstract 1484: SCD-1 blockade sensitizes triple negative breast cancer to immune checkpoint inhibition
Journal Articles

Abstract 1004: Defining stearoyl-CoA desaturase 1 as a molecular therapeutic target against cholangiocarcinoma

Justyna J. Gleba, Laura A. Marlow, Erin E. Miller, James L. Miller, Aylin Alasonyalilar-Demirer, Yi Guo, Kabir Mody, Lewis R. Roberts, Steven R. Alberts, Mark J. Truty, Tushar C. Patel, John A. Copland
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1004.
https://doi.org/10.1158/1538-7445.AM2021-1004
Published: 01 July 2021
View article titled, Abstract 1004: Defining stearoyl-CoA desaturase 1 as a molecular therapeutic target against cholangiocarcinoma
Journal Articles

Abstract 3041: ASPSCR1-TFE3 gene fusion in transgenic mouse as a new pediatric kidney cancer model

Aylin Alasonyalilar-Demirer, James L. Miller, Erin E. Miller, Justyna J. Gleba, Han W. Tun, John A. Copland
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 3041.
https://doi.org/10.1158/1538-7445.AM2021-3041
Published: 01 July 2021
View article titled, Abstract 3041: ASPSCR1-TFE3 gene fusion in transgenic mouse as a new pediatric kidney cancer model
Journal Articles

Abstract C65: Identifying mechanisms of macrophage-mediated metastasis and therapy resistance in PDAC

Tony J. Wu, Oliver Cast, Danish Memon, Alejandro Jimenez-Sanchez, Anne Machel, Sebastian Kehrloesser, Michael B. Gill, Martin L. Miller
Journal: Cancer Research
Cancer Res (2019) 79 (24_Supplement): C65.
https://doi.org/10.1158/1538-7445.PANCA19-C65
Published: 13 December 2019
View article titled, Abstract C65: Identifying mechanisms of macrophage-mediated metastasis and therapy resistance in PDAC
Journal Articles

Comprehensive Benchmarking and Integration of Tumor Microenvironment Cell Estimation Methods

Alejandro Jiménez-Sánchez, Oliver Cast, Martin L. Miller
Journal: Cancer Research
Series: Author Choice
Cancer Res (2019) 79 (24): 6238–6246.
https://doi.org/10.1158/0008-5472.CAN-18-3560
Published: 13 December 2019
View article titled, Comprehensive Benchmarking and Integration of Tumor Microenvironment Cell Estimation Methods
Open the PDF for Comprehensive Benchmarking and Integration of Tumor Microenvironment Cell Estimation Methods in another window
Includes: Supplementary data
Journal Articles

Magnetic Resonance Imaging Is More Sensitive Than PET for Detecting Treatment-Induced Cell Death–Dependent Changes in Glycolysis

Richard L. Hesketh, Jiazheng Wang, Alan J. Wright, David Y. Lewis, Alice E. Denton, Richard Grenfell, Jodi L. Miller, Robert Bielik, Marcel Gehrung, Maria Fala, Susana Ros, Bangwen Xie, De-en Hu, Kevin M. Brindle
Journal: Cancer Research
Cancer Res (2019) 79 (14): 3557–3569.
https://doi.org/10.1158/0008-5472.CAN-19-0182
Published: 15 July 2019
View article titled, Magnetic Resonance Imaging Is More Sensitive Than PET for Detecting Treatment-Induced Cell Death–Dependent Changes in Glycolysis
Open the PDF for Magnetic Resonance Imaging Is More Sensitive Than PET for Detecting Treatment-Induced Cell Death–Dependent Changes in Glycolysis in another window
Includes: Supplementary data
Journal Articles

Abstract 3837: JQ1 induces cell death and disrupts BET protein binding to the MYC locus in cholangiocarcinoma cells

Samuel C. Fehling, Aubrey L. Miller, Karina J. Yoon
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3837.
https://doi.org/10.1158/1538-7445.AM2019-3837
Published: 01 July 2019
View article titled, Abstract 3837: JQ1 induces cell death and disrupts BET protein binding to the MYC locus in cholangiocarcinoma cells
Journal Articles

Abstract 230: Antibody-drug conjugates (ADCs) with indolinobenzodiazepine dimer (IGN) payloads: DNA-binding mechanism of IGN catabolites in target cancer cells

Rajeeva Singh, Luke Harris, Paulin Salomon, Emily E. Reid, Michael L. Miller, Ravi V. Chari, Thomas A. Keating
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 230.
https://doi.org/10.1158/1538-7445.AM2019-230
Published: 01 July 2019
View article titled, Abstract 230: Antibody-drug conjugates (ADCs) with indolinobenzodiazepine dimer (IGN) payloads: DNA-binding mechanism of IGN catabolites in target cancer cells
Journal Articles

Abstract 224: Antibody-drug conjugates (ADCs) of a new class of N-10 amino linked DNA alkylating indolino-benzodiazepines (IGNs)

Michael L. Miller, Emily E. Reid, Katie E. Archer, Luke Harris, Erin K. Maloney, Laura M. Bartle, Olga Ab, Alan J. Wilhelm, Jose F. Ponte, Rajeeva Singh, Thomas A. Keating, Ravi V. Chari
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 224.
https://doi.org/10.1158/1538-7445.AM2019-224
Published: 01 July 2019
View article titled, Abstract 224: Antibody-drug conjugates (ADCs) of a new class of N-10 amino linked DNA alkylating indolino-benzodiazepines (IGNs)
Journal Articles

Abstract 231: Optimizing lysosomal activation of antibody-drug conjugates (ADCs) by incorporation of novel cleavable dipeptide linkers

Paulin Salomon, Luke Harris, Emily E. Reid, Erin K. Maloney, Alan J. Wilhelm, Michael L. Miller, Ravi V. Chari, Thomas A. Keating, Rajeeva Singh
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 231.
https://doi.org/10.1158/1538-7445.AM2019-231
Published: 01 July 2019
View article titled, Abstract 231: Optimizing lysosomal activation of antibody-drug conjugates (ADCs) by incorporation of novel cleavable dipeptide linkers
Journal Articles

Abstract 747: A new class of DNA alkylating indolino-benzodiazepine agents (BIAs) linked with a DNA binding moiety for use with antibody-drug conjugates (ADCs)

Michael L. Miller, Emily E. Reid, Katie E. Archer, Manami Shizuka, Molly A. McShea, Erin K. Maloney, Olga Ab, Leanne Lanieri, Alan J. Wilhelm, Jose F. Ponte, Nicholas C. Yoder, Ravi V. Chari
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 747.
https://doi.org/10.1158/1538-7445.AM2018-747
Published: 01 July 2018
View article titled, Abstract 747: A new class of DNA alkylating indolino-benzodiazepine agents (BIAs) linked with a DNA binding moiety for use with antibody-drug conjugates (ADCs)
Journal Articles

Abstract 5824: The BET inhibitor JQ1 sensitizes cholangiocarcinoma cells to PARP inhibitors

Samuel C. Fehling, Aubrey L. Miller, James E. Bradner, Karina J. Yoon
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 5824.
https://doi.org/10.1158/1538-7445.AM2018-5824
Published: 01 July 2018
View article titled, Abstract 5824: The BET inhibitor JQ1 sensitizes cholangiocarcinoma cells to PARP inhibitors
Journal Articles

Abstract 5643: TCRβ repertoire analysis from a prophylactic MUC1 cancer vaccine trial

Michelle L. Miller, Jason Lohmueller, John R. McKolanis, Robert Schoen, Olivera J. Finn
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 5643.
https://doi.org/10.1158/1538-7445.AM2018-5643
Published: 01 July 2018
View article titled, Abstract 5643: TCRβ repertoire analysis from a prophylactic MUC1 cancer vaccine trial